Here, we show that a specific miRNA, miR-4443, responds to leptin and insulin treatment in CRC-derived cells and that its impaired regulation may contribute to deregulation of downstream signaling, increased cancer metastasis and worse prognosis in a state of leptin resistance. This evidence concerns the gene INS and cancer.